• 552 Citations
  • 13 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1989 2019

  • 552 Citations
  • 13 h-Index
  • 56 Article
  • 5 Review article
Filter
Article
2019
Open Access
irinotecan
Antibody-Dependent Cell Cytotoxicity
Colorectal Neoplasms
oxaliplatin
Therapeutics
Open Access
Colorectal Neoplasms
Therapeutics
aflibercept
Bevacizumab
Survival

Lenvatinib, a molecule with versatile application: From preclinical evidence to future development in anti-cancer treatment

On behalf of ENETs (European NeuroEndocrine Tumor Society) Center of Excellence of Naples, Italy, Jan 1 2019, In : Cancer Management and Research. 11, p. 3847-3860 14 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Thyroid Neoplasms
Receptor, Fibroblast Growth Factor, Type 3
Therapeutics
Vascular Endothelial Growth Factor Receptor

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations

Itanet (Italian Association for Neuroendocrine Tumours), 2019, In : Pancreatology.

Research output: Contribution to journalArticle

Tumor Burden
Neoplasms
Liver
Neoplasm Metastasis
Bone and Bones

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Tafuto, S., von Arx, C., Capozzi, M., Tatangelo, F., Mura, M., Modica, R., Barretta, M. L., Di Sarno, A., Tornesello, M. L., Colao, A. & Ottaiano, A., Aug 15 2019, In : Journal of Clinical Medicine. 8, 8

Research output: Contribution to journalArticle

temozolomide
Safety
Neoplasms
Therapeutics
Dacarbazine
Open Access
Neoplasms
Symptom Assessment
Neuroendocrine Tumors
Neoplasm Metastasis
Gastro-enteropancreatic neuroendocrine tumor
Neuroendocrine Tumors
Multicenter Studies
Observational Studies
Somatostatin
Peptide Receptors
2018

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

Pusceddu, S., Barretta, F., Trama, A., Botta, L., Milione, M., Buzzoni, R., De Braud, F., Mazzaferro, V., Pastorino, U., Seregni, E., Mariani, L., Gatta, G., Di Bartolomeo, M., Femia, D., Prinzi, N., Coppa, J., Panzuto, F., Antonuzzo, L., Bajetta, E., Pia Brizzi, M. & 46 others, Campana, D., Catena, L., Comber, H., Dwane, F., Fazio, N., Faggiano, A., Giuffrida, D., Henau, K., Ibrahim, T., Marconcini, R., Massironi, S., Žakelj, M. P., Spada, F., Tafuto, S., Van Eycken, E., Van Der Zwan, J. M., Žagar, T., Giacomelli, L., Miceli, R., Francesca, A., Alberto, B., Rossana, B., Nicole, B., Sara, C., Carolina, C., Federica, C., Carlo, C., Francesca, C., Marilina, D., Vittoria, D. M., Chiara, D. D., Paola, E., Anna, L. S., Gabriele, L., Giuseppe, L. R., Federico, N., Alessandra, R., Vittorio, P., Paola, R., Maria, R., Sabine, S., Martina, T., Boukje, V. D., Otto, V., Claudio, V. & Group, NEP. W., 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

Pusceddu, S., Barretta, F., Trama, A., Botta, L., Milione, M., Buzzoni, R., De Braud, F., Mazzaferro, V., Pastorino, U., Seregni, E., Mariani, L., Gatta, G., Di Bartolomeo, M., Femia, D., Prinzi, N., Coppa, J., Panzuto, F., Antonuzzo, L., Bajetta, E., Pia Brizzi, M. & 46 others, Campana, D., Catena, L., Comber, H., Dwane, F., Fazio, N., Faggiano, A., Giuffrida, D., Henau, K., Ibrahim, T., Marconcini, R., Massironi, S., Žakelj, M. P., Spada, F., Tafuto, S., Van Eycken, E., Van Der Zwan, J. M., Žagar, T., Giacomelli, L., Miceli, R., Francesca, A., Alberto, B., Rossana, B., Nicole, B., Sara, C., Carolina, C., Federica, C., Carlo, C., Francesca, C., Marilina, D., Vittoria, D. M., Chiara, D. D., Paola, E., Anna, L. S., Gabriele, L., Giuseppe, L. R., Federico, N., Alessandra, R., Vittorio, P., Paola, R., Maria, R., Sabine, S., Martina, T., Boukje, V. D., Otto, V., Claudio, V. & Group, NEP. W., 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

NEPscore Working Group, Jun 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

NEPscore Working Group, Jun 1 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: A real practice study with long-term outcome and prognostic factors

Ottaiano, A., Scotti, V., De Divitiis, C., Capozzi, M., Romano, C., Cassata, A., Casaretti, R., Silvestro, L., Nappi, A., Vicario, V., De Stefano, A., Tafuto, S., Berretta, M., Nasti, G. & Avallone, A., Oct 1 2018, In : Oncotarget. 9, 81, p. 35251-35265 15 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Radiotherapy
Therapeutics
Disease-Free Survival
Survival
Colorectal Neoplasms
Epidermal Growth Factor Receptor
Vascular Endothelial Growth Factor A
Neoplasms
Therapeutics

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 32 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Giacomelli, L., Buzzoni, R., Delle Fave, G., Mazzaferro, V. & de Braud, F., Aug 2018, In : Gastroenterology. 155, 2, p. 479-489.e7

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Metformin
Somatostatin
Disease-Free Survival
Everolimus

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 30 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Buzzoni, R., Mazzaferro, V. & de Braud, F., Aug 1 2018, In : Gastroenterology. 155, 2, p. 479-489.e7

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Metformin
Somatostatin
Disease-Free Survival
Everolimus

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 32 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Giacomelli, L., Buzzoni, R., Delle Fave, G., Mazzaferro, V. & de Braud, F., 2018, In : Gastroenterology. 155, 2, p. 479

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Metformin
Somatostatin
Disease-Free Survival
Everolimus

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 32 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Giacomelli, L., Buzzoni, R., Delle Fave, G., Mazzaferro, V. & de Braud, F., Aug 2018, In : Gastroenterology. 155, 2, p. 479-489.e7

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Metformin
Somatostatin
Disease-Free Survival
Everolimus

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 32 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Giacomelli, L., Buzzoni, R., Delle Fave, G., Mazzaferro, V. & de Braud, F., 2018, In : Gastroenterology. 155, 2, p. 479-489.e7

Research output: Contribution to journalArticle

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Pusceddu, S., Vernieri, C., Di Maio, M., Marconcini, R., Spada, F., Massironi, S., Ibrahim, T., Brizzi, M. P., Campana, D., Faggiano, A., Giuffrida, D., Rinzivillo, M., Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., De Divitiis, C., Ermacora, P., Perfetti, V. & 32 others, Fontana, A., Razzore, P., Carnaghi, C., Davì, M. V., Cauchi, C., Duro, M., Ricci, S., Fazio, N., Cavalcoli, F., Bongiovanni, A., La Salvia, A., Brighi, N., Colao, A., Puliafito, I., Panzuto, F., Ortolani, S., Zaniboni, A., Di Costanzo, F., Torniai, M., Bajetta, E., Tafuto, S., Garattini, S. K., Femia, D., Prinzi, N., Concas, L., Lo Russo, G., Milione, M., Giacomelli, L., Buzzoni, R., Delle Fave, G., Mazzaferro, V. & de Braud, F., 2018, In : Gastroenterology. 155, 2, p. 479

Research output: Contribution to journalArticle

Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme

Barbarisi, M., Iaffaioli, R. V., Armenia, E., Schiavo, L., De Sena, G., Tafuto, S., Barbarisi, A. & Quagliariello, V., Oct 1 2018, In : Journal of Cellular Physiology. 233, 10, p. 6550-6564 15 p.

Research output: Contribution to journalArticle

temozolomide
Quercetin
Hyaluronic Acid
Glioblastoma
Brain Neoplasms

Obesity and cancer: biological links and treatment implications

Ottaiano, A., De Divitiis, C., Capozzi, M., Avallone, A., Pisano, C., Pignata, S. & Tafuto, S., 2018, In : Current Cancer Drug Targets.

Research output: Contribution to journalArticle

Obesity
Neoplasms
Therapeutics
Body Mass Index
Long-Term Synaptic Depression
2017
gemcitabine
National Cancer Institute (U.S.)
Pancreatic Neoplasms
Pancreas
Adenocarcinoma
2016

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR

Circelli, L., Sciammarella, C., Guadagno, E., Tafuto, S., de Caro, M. D. B., Botti, G., Pezzullo, L., Aria, M., Ramundo, V., Tatangelo, F., Losito, N. S., Ieranò, C., D'Alterio, C., Izzo, F., Ciliberto, G., Colao, A., Faggiano, A. & Scala, S., 2016, In : Oncotarget. 7, 14, p. 18865-18875 11 p.

Research output: Contribution to journalArticle

CXC Chemokines
Neuroendocrine Tumors
Chemokine Receptors
Sirolimus
Chemokine CXCL12

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Ottaiano, A., Nappi, A., Tafuto, S., Nasti, G., De Divitiis, C., Romano, C., Cassata, A., Casaretti, R., Silvestro, L., Avallone, A., Capuozzo, M., Capozzi, M., Maiolino, P., Quagliariello, V., Scala, S. & Iaffaioli, V. R., Jan 1 2016, In : Oncology. 90, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

oxaliplatin
Adjuvant Chemotherapy
Colonic Neoplasms
Body Mass Index
Disease-Free Survival

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): A randomised, placebo-controlled, phase 3 study

Yao, J. C., Fazio, N., Singh, S., Buzzoni, R., Carnaghi, C., Wolin, E. M., Tomasek, J., Raderer, M., Lahner, H., Voi, M., Pacaud, L. B., Rouyrre, N., Sachs, C., Valle, J. W., Fave, G. D., Van Cutsem, E., Tesselaar, M., Shimada, Y., Oh, D. Y., Strosberg, J. R. & 3 others, Kulke, M. H., Pavel, M. E. & Tafuto, S., 2016, In : The Lancet. 387, 10022, p. 968-977 10 p.

Research output: Contribution to journalArticle

temozolomide
Neuroendocrine Carcinoma
Tumors
Cisplatin
Toxicity
temozolomide
Neuroendocrine Carcinoma
Tumors
Cisplatin
Toxicity

Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: An observational retrospective-prospective analysis from real life

Faggiano, A., Carratù, A. C., Guadagno, E., Tafuto, S., Tatangelo, F., Riccardi, F., Mocerino, C., Palmieri, G., Damiano, V., Siciliano, R., Leo, S., Mauro, A., Tozzi, L. F., De Rosa, G. & Colao, A., 2016, In : Oncotarget. 7, 5, p. 5538-5547 10 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Somatostatin
Neoplasms
Thorax
Octreotide

Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: An observational retrospective-prospective analysis from real life

Faggiano, A., Carratù, A., Guadagno, E., Tafuto, S., Tatangelo, F., Riccardi, F., Mocerino, C., Palmieri, G., Damiano, V., Siciliano, R., Leo, S., Mauro, A., Tozzi, L., Battista, C., De Rosa, G. & Colao, A., 2016, In : Oncotarget. 7, 5, p. 5538-5547 10 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Somatostatin
Neoplasms
Thorax
Octreotide
2015
Neuroendocrine Tumors
Somatostatin
Ileum
Neoplasms
Octreotide

Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases

Tafuto, S., von Arx, C., De Divitiis, C., Tracey Maura, C., Palaia, R., Albino, V., Fusco, R., Membrini, M., Petrillo, A., Granata, V. & Izzo, F., Sep 1 2015, In : International Journal of Surgery. 21, S1, p. S78-S82

Research output: Contribution to journalArticle

Electrochemotherapy
Liver Neoplasms
Pancreatic Neoplasms
Neoplasm Metastasis
Drug Administration Routes

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it

Capozzi, M., Caterina, I., De Divitiis, C., von Arx, C., Maiolino, P., Tatangelo, F., Cavalcanti, E., Di Girolamo, E., Iaffaioli, R. V., Scala, S. & Tafuto, S., Sep 1 2015, In : International Journal of Surgery. 21, S1, p. S89-S94

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Sirolimus
Drug Resistance
Neoplasms
Appendix

Letter: The response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score

Faggiano, A., Carratù, A. C., Guadagno, E., Tafuto, S., Tatangelo, F., Riccardi, F., Mocerino, C., Palmieri, G., Damiano, V., Siciliano, R., Leo, S., Mauro, A., Tozzi, L. F., Battista, C., De Rosa, G. & Colao, A., Oct 1 2015, In : Alimentary Pharmacology and Therapeutics. 42, 8, p. 1033-1034 2 p.

Research output: Contribution to journalArticle

2014

Hepatic arterial embolization in patients with neuroendocrine tumors

Del Prete, M., Fiore, F., Modica, R., Marotta, V., Marciello, F., Ramundo, V., Di Sarno, A., Carratù, A., Di Roseto, C. D. L., Tafuto, S., Tatangelo, F., Baldelli, R., Colao, A. & Faggiano, A., May 19 2014, In : Journal of Experimental and Clinical Cancer Research. 33, 1, 43.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Neoplasm Metastasis
Liver
Neoplasms
Vascular Tissue Neoplasms

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Bajetta, E., Floriani, I., Di Bartolomeo, M., Labianca, R., Falcone, A., Di Costanzo, F., Comella, G., Amadori, D., Pinto, C., Carlomagno, C., Nitti, D., Daniele, B., Mini, E., Poli, D., Santoro, A., Mosconi, S., Casaretti, R., Boni, C., Pinotti, G., Bidoli, P. & 169 others, Landi, L., Rosati, G., Ravaioli, A., Cantore, M., Di Fabio, F., Aitini, E., Marchet, A., Rulli, E., Cropalato Di Tullio, M., Galli, F., Biagioli, E., De Simone, I., Mangano, S., Tonato, M., Zucca, E., Valsecchi, M. G., De Placido, S., Catena, L., Schiavo, M., Proserpio, I., Bordonaro, R., Cordio, S., Burrafato, G., Bochicchio, A. M., Aieta, M., Fazio, N., Spada, F., Amoroso, V., Marini, G., Soto Parra, H., Novello, G., Massidda, B., Ionta, M. T., Comandè, M., Venezia, R., Bertolini, A., Menatti, E., Zanlorenzi, L., Colombo, A., Iop, A., Bonura, S., Mazza, E., Viganò, M., Ardizzoia, A., Dell'Oro, S., Lo Re, G., Santeufemia, D., Buonadonna, A., Luisi, D., Ucci, G., Di Lucca, G., Bonetti, A., Bergamo, F., Alù, M., Vastola, F., Marchetti, P., Corsi, D. C., Massa, E., Di Pinto, G., Duro, M., Oliani, C., Franchini, M., Inzoli, A., Gebbia, N., Repetto, L., Rota, S., Frontini, L., Quadri, A., De Grossi, S., Cazzaniga, M. E., Villa, F., Foa, P., Ferrari, D., Rabbi, C., Barni, S., Petrelli, F., Giordano, M., Luchena, G., Pirovano, M., Nasisi, A., Catalano, V., Giordani, P., Zaniboni, A., Leone, F., Ferrario, S., Beretta, G. D., Menichetti, E. T., Conte, D., Mari, D., Giannicola, R., Pierantoni, C., Luporini, A. G., Ragazzini, M. A., Tassinari, D., Nicolini, M., Frassineti, G. L., Turci, D., Zumaglini, F., Tamberi, S., Piancastelli, A., Cruciani, G., Bejtja, E., Minuti, G., Orlandi, M., Mambrini, A., Ciarlo, A., Cavaciocchi, D., Del Monte, F., Ricci, S., Brunetti, I. M., Lencioni, M., Sisani, M., Sozzi, P., Granetto, C., Chiara, S., Galetto, A. S., Ribecco, A. S., DeCensi, A., Ciuffreda, L., Baldini, E. E., Camisa, R., Todeschini, R., Rimassa, L., Carnaghi, C., Pressiani, T., Rondini, E., Gnoni, R., Gasperoni, S., Cavanna, L., Palladino, M. A., Mattioli, R., Laici, G., Pucci, F., Alessio, M. D., Bernardini, I., Tomasello, G., Baldino, G., Rossetti, R., Giaquinta, S., Rijas Llimpe, F. L., Brandes, A. A., Marzola, M., Competiello, S., Montesarchio, V., Rea, A., Genua, G., Licenziato, M., Silvestro, L., Montano, M., Sarobba, M. G., Sanna, G., Filippelli, G., Dima, G., Greco, E., Roselli, M., Natale, D., Condemi, G., Fumi, G., Tafuto, S., Masullo, P., Tiberio, G., de Manzoni, G., Nobili, S., Fiorentini, G., Mazzanti, R., Perrotta, E., De Stefano, A., Cartenì, G. & Otero, M., 2014, In : Annals of Oncology. 25, 7, p. 1373-1378 6 p., mdu146.

Research output: Contribution to journalArticle

docetaxel
Leucovorin
Fluorouracil
Cisplatin
Stomach Neoplasms
2013
Colorectal Neoplasms
Pancreatic Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
Geriatric Assessment
2011

Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF regimen) in patients with metastatic colorectal cancer: The southern Italy cooperative oncology group experience

Comella, P., Massidda, B., Natale, D., Putzu, C., Sandomenico, C., Filippelli, G., Palmeri, S., Condemi, G., Vessia, G., Barberis, G., Ionta, M. T., Tafuto, S. & Barbato, E., 2011, In : Clinical Colorectal Cancer. 10, 1, p. 42-47 6 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Fluorouracil
Italy
Colorectal Neoplasms
2010

Amyloid in bone marrow smears of patients affected by multiple myeloma

Petruzziello, F., Zeppa, P., Catalano, L., Cozzolino, I., Gargiulo, G., Musto, P., D'Auria, F., Liso, V., Rizzi, R., Caruso, N., Califano, C., Piro, E., Musso, M., Bonanno, V., Pia Falcone, A., Tafuto, S., Di Raimondo, F., De Laurentiis, M., Pane, F., Palombini, L. & 1 others, Rotoli, B., May 2010, In : Annals of Hematology. 89, 5, p. 469-474 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Amyloid
Bone Marrow
Amyloid Plaques
Birefringence

Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet

Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., Franco, L., Massidda, B., Filippelli, G., Putzu, C., Natale, D., Barberis, G., Maiorino, L., Palmeri, S., Cannone, M., Condemi, G., Leo, S., Tafuto, S., Greco, E., Roselli, M. & 6 others, Milia, V., Gambardella, A., Mancarella, S., Di Pinto, G., De Luca, L. & Vessia, G., 2010, In : Acta Oncologica. 49, 1, p. 50-56 7 p.

Research output: Contribution to journalArticle

oxaliplatin
Colorectal Neoplasms
Survival
Disease-Free Survival
Alkaline Phosphatase
2006

Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma

Tafuto, S., Muto, P., Tortoriello, A., Pisano, A., Comella, P., Formato, R., Quattrin, S. & Iaffaioli, R. V., 2006, In : Frontiers in Bioscience. 11, 1 P.447-888, p. 502-505 4 p.

Research output: Contribution to journalArticle

temozolomide
Lomustine
Glioma
Chemotherapy
Therapeutics

Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomas

Tafuto, S., Catalano, O., Barba, G., Sandomenico, F., Lobianco, R., Tortoriello, A., Formato, R., Comella, P., Siani, A., Di Meo, M., Iaffaioli, R. V. & Quattrin, S., 2006, In : Frontiers in Bioscience. 11, SUPPL. 1, p. 2224-2229 6 p.

Research output: Contribution to journalArticle

Computerized tomography
Italy
Lymphoma
Ultrasonics
Ultrasonography
2005

A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group trial 0108

Comella, P., Gambardella, A., Farris, A., Maiorino, L., Natale, D., Massidda, B., Casaretti, R., Tafuto, S., Lorusso, V. & Leo, S., Feb 2005, In : Critical Reviews in Oncology/Hematology. 53, 2, p. 133-139 7 p.

Research output: Contribution to journalArticle

oxaliplatin
Italy
Colorectal Neoplasms
Capecitabine

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: A Southern Italy Cooperative Oncology Group phase II study

Comella, P., Massidda, B., Palmeri, S., Farris, A., Lucia, L. D., Natale, D., Maiorino, L., Tafuto, S., Cataldis, G. D. & Casaretti, R., Nov 2005, In : Cancer Chemotherapy and Pharmacology. 56, 5, p. 481-486 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Oncology
Italy
Colorectal Neoplasms
Disease control

Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: Final results of the Southern Italy Cooperative Oncology Group trial 0108

Comelia, P., Natale, D., Farris, A., Gambardella, A., Maiorino, L., Massidda, B., Casaretti, R., Tafuto, S., Lorusso, V., Leo, S. & Cannone, M., Jul 15 2005, In : Cancer. 104, 2, p. 282-289 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Italy
Colorectal Neoplasms
Therapeutics
Fluorouracil

Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase III trial

Comella, P., Massidda, B., Filippelli, G., Palmeri, S., Natale, D., Farris, A., De Vita, F., Buzzi, F., Tafuto, S., Maiorino, L., Mancarella, S., Leo, S., Lorusso, V., De Lucia, L. & Roselli, M., Jun 2005, In : Annals of Oncology. 16, 6, p. 878-886 9 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Leucovorin
Fluorouracil
Italy

Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.

Comella, P., Massidda, B., Filippelli, G., Natale, D., Farris, A., Buzzi, F., Tafuto, S., Maiorino, L., Palmeri, S., De Lucia, L., Mancarella, S., Leo, S., Roselli, M., Lorusso, V. & De Cataldis, G., Sep 2005, In : Clinical Colorectal Cancer. 5, 3, p. 203-210 8 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Fluorouracil
Italy
Weight Loss
2002

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group

Comella, P., Crucitta, E., De Vita, F., De Lucia, L., Farris, A., Del Gaizo, F., Palmeri, S., Iannelli, A., Mancarella, S., Tafuto, S., Maiorino, L., Buzzi, F., De Cataldis, G., Casaretti, R., Avallone, A., Montella, M., Comella, G., Orditura, M., Catalano, G., Lorusso, V. & 18 others, De Lena, M., Biglietto, M., Sanna, G., Sarobba, M. G., Belli, C., Russo, A., Pizzardi, V., Accurso, V., Musca, A., Gravina, A., Leopaldi, G., Brunetti, C., Muci, D., Leo, S., Avino, F., De Luca, L., Greco, E. & Aiello, C., 2002, In : Annals of Oncology. 13, 6, p. 866-873 8 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Methotrexate
Fluorouracil
Italy
1995

A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy

Tafuto, S., Abate, G., D'Andrea, P., Silvestri, I., Marcelin, P., Volta, C., Monteverde, A., Colombi, S., Andorno, S. & Aglietta, M., 1995, In : European Journal of Cancer. 31, 1, p. 46-49 4 p.

Research output: Contribution to journalArticle

Carboplatin
Etoposide
Granulocyte-Macrophage Colony-Stimulating Factor
Appointments and Schedules
Drug Therapy

Three-year results of MIM salvage treatment for refractory/relapsed intermediate grade NHL [2]

Abate, G., Tafuto, S., Marcacci, G., Corazzelli, G., Fimiani, P., Monda, V. M., Gailli, E., D'Andrea, P. & Iaccarino, G., 1995, In : European Journal of Haematology. 54, 1, p. 53-54 2 p.

Research output: Contribution to journalArticle

1994

Interleukin-6: Biological features and clinical implications

Tafuto, S., Silvestri, I., D'Andrea, P., Ronga, D. & Abate, G., 1994, In : Journal of Biological Regulators and Homeostatic Agents. 8, 1, p. 1-8 8 p.

Research output: Contribution to journalArticle